Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
When using hyperfractionation with a BID regimen, what are typical dose constraints for the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Similar to 2 Gy once daily with a little more wiggle room
Sign In
or
Register
to read more
17721
Related Questions
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?